Synthesis of the Core Oligosaccharides of Lipooligosaccharides from Campylobacter jejuni: A Putative Cause of Guillain-Barré Syndrome.


Journal

Chemistry (Weinheim an der Bergstrasse, Germany)
ISSN: 1521-3765
Titre abrégé: Chemistry
Pays: Germany
ID NLM: 9513783

Informations de publication

Date de publication:
14 Jan 2019
Historique:
received: 25 09 2018
pubmed: 24 10 2018
medline: 1 2 2019
entrez: 24 10 2018
Statut: ppublish

Résumé

The chemical synthesis of the highly branched core oligosaccharides of lipooligosaccharides (LOSs) found in Campylobacter jejuni, which causes Guillain-Barré syndrome by a preceding infection, is described. The target LOS mimics, consisting of eight or nine monosaccharides, were classified into three groups as key building blocks: ganglioside-core tetra-/pentasaccharides (GM1-/GD1a-like), l-glycero-d-manno-heptose-containing trisaccharides, and 3-deoxy-d-manno-2-octulosonic acid (KDO) residues. These synthetic fragments were obtained from commercially available monosaccharides. Less obtainable l-glycero-d-manno-heptose and KDO residues, as key components of the LOSs, were synthesized from p-methoxyphenyl d-mannoside and di-O-isopropylidene-protected d-mannose, respectively. The synthesis of α-KDO glycoside, as one of the most difficult stereocontrolled glycosidic constructions, was achieved by treating a 2,3-ene derivative of KDO with phenylselenyl trifluoromethanesulfonate as a suitable α-directing reagent. All synthetic blocks were constructed through a convergent synthetic route, which resulted in the first synthesis of structurally challenging LOS core glycans containing ganglioside GM1 and GD1a-core sequences.

Identifiants

pubmed: 30351481
doi: 10.1002/chem.201804862
doi:

Substances chimiques

Gangliosides 0
Lipopolysaccharides 0
Oligosaccharides 0
Trisaccharides 0
lipid-linked oligosaccharides 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

796-805

Subventions

Organisme : Japan Society for the Promotion of Science
ID : 10660107

Informations de copyright

© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Auteurs

Fumi Yoshida (F)

Department of Applied Bio-organic Chemistry, Gifu University, 1-1 Yanagido, Gifu-shi, Gifu, 501-1193, Japan.

Hiroki Yoshinaka (H)

Department of Applied Bio-organic Chemistry, Gifu University, 1-1 Yanagido, Gifu-shi, Gifu, 501-1193, Japan.

Hidenori Tanaka (H)

Center for Highly Advanced Integration and Nano and Life Sciences, (G-CHAIN), Gifu University, 1-1 Yanagido, Gifu-shi, Gifu, 501-1193, Japan.

Shinya Hanashima (S)

Structural Glycobiology Team, Systems Glycobiology Research Group, RIKEN Global Research Cluster, 2-1 Hirosawa, Wako, Saitama, 351-0198, Japan.

Yoshiki Yamaguchi (Y)

Structural Glycobiology Team, Systems Glycobiology Research Group, RIKEN Global Research Cluster, 2-1 Hirosawa, Wako, Saitama, 351-0198, Japan.

Mikio Ishihara (M)

Department of Applied Bio-organic Chemistry, Gifu University, 1-1 Yanagido, Gifu-shi, Gifu, 501-1193, Japan.

Miyuki Saburomaru (M)

Department of Applied Bio-organic Chemistry, Gifu University, 1-1 Yanagido, Gifu-shi, Gifu, 501-1193, Japan.

Yuki Kato (Y)

Department of Applied Bio-organic Chemistry, Gifu University, 1-1 Yanagido, Gifu-shi, Gifu, 501-1193, Japan.

Risa Saito (R)

Department of Applied Bio-organic Chemistry, Gifu University, 1-1 Yanagido, Gifu-shi, Gifu, 501-1193, Japan.

Hiromune Ando (H)

Center for Highly Advanced Integration and Nano and Life Sciences, (G-CHAIN), Gifu University, 1-1 Yanagido, Gifu-shi, Gifu, 501-1193, Japan.

Makoto Kiso (M)

Department of Applied Bio-organic Chemistry, Gifu University, 1-1 Yanagido, Gifu-shi, Gifu, 501-1193, Japan.

Akihiro Imamura (A)

Department of Applied Bio-organic Chemistry, Gifu University, 1-1 Yanagido, Gifu-shi, Gifu, 501-1193, Japan.

Hideharu Ishida (H)

Department of Applied Bio-organic Chemistry, Gifu University, 1-1 Yanagido, Gifu-shi, Gifu, 501-1193, Japan.
Center for Highly Advanced Integration and Nano and Life Sciences, (G-CHAIN), Gifu University, 1-1 Yanagido, Gifu-shi, Gifu, 501-1193, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH